The settlement of a consumer protection action brought by 38 states against two drug companies will yield $1 million to the State of Washington, Attorney General Rob McKenna said today.
Washington’s windfall will come from a $40.75 million settlement agreed to by GlaxoSmithKline LLC and SB Pharmco Puerto Rico.
The attorneys general claimed there were defects in the manufacturing of the drugs in a plant in Cidra, Puerto Rico. The Cidra plant has been closed since 2009.
Four drugs were involved in the claim, Kytril, Bactroban, Paxil CR and Avandamet. All of the products involved in the manufacturing problem were recalled several years ago.
The money from the settlement will be used to pay the costs of the litigation and to fund consumer protection enforcement or medical health programs.